Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CV > HTN II > Flashcards

HTN II Flashcards

1
Q
  1. What BP is HTN for home monitoring?

2. 24-hr BP Dx of HTN

A
  1. > 135/85 mmHg (office measure is 140/90)

2. >130/80 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

BP Follow-Up Timeline:

  1. Normal
  2. Pre-HTN
  3. Stage 1
  4. Stage 2
A
  1. Recheck in 2 years
  2. Recheck in 1 year
  3. Confirm w/in 1 month
  4. Evaluate or refer w/in 2 weeks

If BP is =/> 180/110, evaluate and treat immediately or within 1 week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Initial Dx of HTN: 3 key steps

A
  1. Identify possible secondary causes of high blood pressure
  2. Identify other cardiovascular disease
    risk factors
  3. Assess for target organ damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Physical Exam for Dx HTN

A 
Physical Examination
•
Check the BP in both arms
•
Obtain orthostatic blood pressures (especially elderly)
•
Cardiac: palpation and auscultation
•
Vascular: pulses, carotid, abdominal, 
and femoral bruits
•
Abdomen: masses and aortic pulsation
•
Lower extremities: edema
•
Palpate thyroid
•
Examine optic fundi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Initial Lab Tests

A 
Initial Laboratory Tests
•
Urinalysis 
•
Blood glucose
•
Hematocrit
•
Serum potassium 
•
Serum calcium
•
Serum 
creatinin, GFR
•
12-lead ECG
•
TSH
•
Fasting lipid panel: HDL-c, LDL-c, TGs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Major classes of anti-HTN drugs:

A 
•
Angiotensin
-converting enzyme inhibitors
•
Angiotensin receptor 
blockers
•
Calcium channel 
blockers 
•
Diuretics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Other anti-HTN drugs

A 
•
β-Blockers
•
α-Blockers
•
Direct vasodilators
•
Aldosterone 
antagonists
•
Direct renin 
inhibitors
•
Central α2 agonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What drugs must you not use for HTN in pregnant women?

A

ACE-inhibitors, angiotensin receptor blockers, renin inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ACE-inhibitors:

  1. Name/example:
  2. Mechanism
  3. Effects
  4. Side Effects
  5. Misc.
A
  1. “…pril”–captopril
  2. Bind to angiotensin converting enzyme
  3. Effects:
    a) ++ Ang I
    b) – Ang II
    c) ++ Renin
    d) – aldosterone
    e) –peripheral arterial resistance
    f) –intravascular volume
  4. CATCHH
  5. Protects the kidneys: dilates vessels, lowers intraglomerular pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACE-I Side Effects

A

CATCHH

a) Cough
++ BK in lungs
5-20%
dose-dependent

b) angioedema
*potentiation of BK
>90% can take an ARB
-usually in 1st month
-Swelling of tongue and laryngeal mucosa
•Greater risk among African
Americans

c) teratogen
- Need Ang II for fetal kidney

d) creatine bump (up to 30%)
- can cause worsening renal fxn in those with CKD, renal artery stenosis, cardiomyopathy, DM

e) hyperkalemia
- typical of all RAAS inhibitors
- Na+/K+ pump: we dump Na+ therefore we keep K+

f) hypotension-blocking RAAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Angiotensin Receptor Blockers (ARBs)

  1. Name/example:
  2. Mechanism
  3. Effects
  4. Side Effects
  5. Misc.
A
  1. “…sartan”
  2. Selectively block AT1 receptor; thus Ang II can’t bind
  3. Effects:
    a) ++ Renin
    b) – aldosterone
    c) –peripheral arterial resistance
    f) –intravascular volume
    g) inhibits sympa activation, vasoconstriction, cell growth, Na+ fluid retention
  4. Similar S/E to ACE-i but better S/E profile
    - hyperkalemia
    - ++creatinine
  5. No effect on BK (thus less incidence of cough and angioedema)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AT1 Receptor

A

Blocked by ARBs from binding Angiotensin II

Normally: vasoconstriction, sympathetic activation, cell growth, Na+ fluid retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diuretics:

  1. Mechanism
  2. Effects
  3. Side Effects
  4. Loop
  5. Thiazide
  6. Misc.
A
  1. Increase urinary excretion of sodium
    at various sites in the kidney
  2. Venodilation, decreases intravascular
    volume, lowering blood pressure
3. Side Effects: 
Volume depletion
•
Hypotension, orthostasis
•
Electrolyte changes:
−Hypokalemia
−Hypomagnesemia
−Hyponatremia
(thiazide)
−Hypercalcemia
(thiazide)
•Hyperkalemia 
(potassium sparing) 
diuretics)
-stable after 1st 3-7 days 
•
Ototoxicity (Loop)
•
Metabolic 
side 
effects:
−Hyperglycemia
−Hypercholesterolemia
−Hyperuricemia (loop)-->gouty arthritis 
•
Erectile 
dysfunction
•
Sulfa-allergy
  1. Loop: more potent
    - ex) furosemide
    - great in decompensated heart failure
    - potent venodilators, natriuretic agent
    - S/E: ototoxicity, ++Ca2+ excretion–>worsens osteoporosis
  2. Thiazide
    ex) hydrochlorothiazide (chlorthalidone)
    - cheap and useful
    - Decreases ECF and dilates peripheral arterioles
    a) short term effects (1-2 weeks): decreases ECF volume, small bump in peripheral resistance, decreased BP
    b) long-term effects: Steady lower levels of BP, peripheral resistance, and fluid volume
    - as CO returns to baseline, SVR decreases
  3. Not good for diabetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ca2+ Channel Blockers

  1. Mechanism
  2. Effects:
  3. Dihydropyridine
  4. Non-dihydropyridine
  5. Side Effects
A
  1. L-type Ca2+
    channels: Ca2+ influx and smooth muscle contraction
    •
    CCBs bind
    to receptors:
    -vasodilate arteriolar smooth muscle
    -decrease peripheral
    vascular resistance
  2. Effects:
    * ++ RBF–> ++nariuresis
    * dilating afferent arterioles
    * ++glomerular filtration pressure
  3. Dihydropyridine (amlodipine)
    -Decrease Ca2+ influx into vascular SMCs
    -chronic use-little effect on resting HR
    -Can cause reflex tachycardia
    S/E (due to arteriolar dilation): edema, headache, flushing, dizziness,
    palpitations
  4. Non-dihydropyridine
    -verapamil, diltiazem
    -also decrease Ca2+ influx into myocardium (decreases HR)
    -S/E: bradycardia, AV
    block, CONSTIPATION
  5. General S/E:
    -Gingival hyperplasia
    -Aggravate
    gastroesophageal
    reflux due to
    inhibition of LES
    contraction
    -inhibits CYP34A: increasing blood levels of other meds
    -hypotension
    -headache
    -ankle edema
    -nausea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Direct Renin Inhibitors

  1. Mechanism
  2. Warnings
  3. Side Effects
  4. Example
  5. Advantages?
A
  1. Blocks the “rate
    limiting step” of
    RAAS
2. Do not use with 
ACE-I or ARB: 
Increased incidence of 
nonfatal stroke, 
worsening kidney 
function especially 
with diabetes

3.Side effects overlap
with ACE-Is and ARBs

  1. Aliskiren
  2. ACE-Is and ARBs cause compensatory increase in renin (decreases their efficacy), whereas renin inhibitors do not
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Aldosterone Antagonists

  1. Mechanism
  2. Effects
  3. Benefits
  4. Risks
  5. Spironolactone
  6. Eplenerone
A
  1. Aldosterone interacts with mineralcorticoid
    receptors; Antagonist BLOCK receptors
  2. Effects:
    * –NaCl reabsorption
    * blocks vasoconstriction
    * blocks endothelial dysfunction
    * blocks hypertrophy of vascular SMCs
  3. Beneficial in resistant hypertension and
    when combined with other diuretics
  4. Increased risk of hyperkalemia when
    combined with
    ACE-I or ARB
5. Spironolactone (non-selective): 
−Men: erectile dysfunction, 
gynecomastia (10%) 
−Women: menstrual 
abnormalities
-also helps in heart failure
  1. Eplerenone
    (selective) -better S/E profile
17
Q 
β-Adrenoceptor
Blockers (β-Blockers)
1. Effects: 
2. B1 vs. B2 
3. Intrinsic sympathomimetic activity
4.Vasodilatory Properties 
5.  Misc.
A

“…lol”

  1. Effects: Generally inhibits effects of catecholamines (Epi and NE), decreasing SNS activity
•Decreased CO, inhibit renin secretion, inhibit NE release 
•Reductions in HR due to decreased automaticity in sinus 
node (negative 
chronotropic
effect)
•Reduces ventricular hypertrophy, 
stroke, heart failure, coronary events, 
and mortality
  1. •β1 (selective): myocardium, less effect
    on airways
    •β2 (non-selective): myocardium, vascular, bronchial cells
  2. weak β-adrenergic activation
  3. (ex: carvedilol):
    antagonize α-adrenergic receptor and increase NO release
  4. Not 1st line HTN tx
    - used for heart failure
  5. Side Effects:
    •Bradycardia, heart block, dizziness
    •Bronchospasm, cold extremities (β2 effect)
    •CNS effects: fatigue, depression, mental
    slowness, vivid dreams, dry mouth
    •Erectile
    dysfunction,
    hyperglycemia
    •Lipid abnormalities (triglyceride elevation,
    HDL reduction)
18
Q

Direct Vasodilators:

General

A

•Usually given
with a diuretic and
β-blocker to prevent
“pseudotolerance”
−compensatory increased SNS activity and increased RAAS: Tachycardia and edema
•4th or 5th line due to side effects and dosing frequency

19
Q

Direct Vasodilators: Hydralazine

A 
•Directly relaxes vascular smooth muscle
•Decreases peripheral resistance      
•Metabolism is genetically determined
−N-acetyltransferase
-Takes places in liver 
-Slow acetylators: greater S/E's
•high doses increase risk for lupus-like syndrome rxn 
•parenterally for HTN Emergency
20
Q

Direct Vasodilators:

Minoxidil

A

•more potent
•Opens K+channels in vascular SMC
•Similar hemodynamics as hydralazine
•Most useful in patients with severe hypertension
•Use limited by S/E: pericardial effusion (3%),
tachycardia, facial hirsutism, elevated pulmonary artery pressure
-ST segment depression
-T-wave changes due to increased myocardial demand
•rapidly absorbed via GI

21
Q

α-Adrenergic Receptor Blockers

A 
•Selective α1-antagonists
-Blocks site for norepinephrine, inhibiting SMC contraction
•Decrease arteriolar resistance
•Beneficial in patients with prostate 
symptoms (ex:doxazosin) to decrease urinary symptoms 
•Side effects: 
−Postural hypotension
−Dizziness, syncope
−Reflex tachycardia
−Nasal congestion 
−Volume expansion
  • *not a monotherapy
  • **Non-selective a-adrenergic receptor blockers are NOT effective for HTN
22
Q

Central

Sympatholytics

A

•α2 agonists (clonidine, methyldopa)

•Directly reduce sympathetic outflow to the heart and blood vessels by acting on BS
-stimulation inhibits SNS–>vasodilation

•Side-effects: sedation, DRY MOUTH, erectile dysfunction, depression

•Clonidine: rapid onset
-REBOUND hypertension, skin hypersensitivity (20%)

•Methyldopa: pregant HTN
-Coombs’positive hemolytic anemia, elevated lever function tests

23
Q

Compelling
Indications for
Specific Blood Pressure Medication Classes:

  1. Heart Failure
A

ARB (or ACE-I) + β-blocker + diuretic + spironolactone;

Add dihydropyridinefor
improved BP control if needed

24
Q 
Compelling 
Indications for 
Specific Blood Pressure Medication Classes: Post-myocardial 
infarction/Coronary 
Artery Disease
A

1st: ACE-I (or ARB) + β-blocker*
2nd: CCB or thiazide diuretic
* some patients will need a β-blocker based on LV ejection fraction

25
Q

Compelling
Indications for
Specific Blood Pressure Medication Classes: DM or CKD

A

1st: ACE-I (or ARB)
2nd: CCB or diuretic

Goal for DM:

26
Q

Compelling
Indications for
Specific Blood Pressure Medication Classes:Recurrent Stroke Prevention

A

1st: ACE-I (or ARB)
2nd: Thiazide or CCB

27
Q

Hypertensive Urgency/Emergency

*Medications for either

A 
•Urgency: high blood pressure but 
without acute target organ damage
−Receive immediate treatment with oral 
(+/− IV)antihypertensive 
therapy

•Emergency: Severe hypertension and
acute target organ damage
−Requires hospitalization and immediate parenteral medication therapy
-pulmonary edema, MI, stroke, retinal bleeding
-Tx Goal: reduce MAP by no more than 25% w/in 2 hours or decrease to approx. 160/100

  • Meds generally for emergency:
    1. Vasodilators:
  • nitroprusside
  • nitroglycerine
  • hydralazine
  • enalapril
  1. Adrenergic Inhibitors
    - Labetalol (a, B-blocker)
    - esmolo (B1-selective blocker)

**Can use the above for urgency, but usually oral clonidine

28
Q

Resistant Hypertension

  1. Definition
  2. Dx
  3. Risk Factors/Characteristics of Pts
A

Resistant Hypertension
1. •BP ≥140/90 mmHg while on 3 different
BP medication classes (incl. diuretic)
−or on 4 antihypertensive drug
classes regardless of
blood pressure
-significant factor: excess Na+ retention–>excess volume
-obesity –> impaired Na+ excretion, increased SNS, sleep apnea

  1. •Exclude pseudo-resistance (make sure they’re taking their meds)
    •Identify and reverse contributing
    factors
    •Discontinue/minimize interfering substances: alcohol, OTCs, drugs, other meds
    •Screen for secondary causes
  2. Factors:
    - Older
    - obese
    - LVH
    - Na+/volume retention
    - female
    - African American
    - DM
    - CKD
29
Q

Factors Affecting Patient Adherence

A 
Misunderstanding of condition or need 
for treatment
•
Absence of symptoms
•
Adverse effects of medications
•
Cost and simplicity of medication 
regimen
•
Cost of follow-up visits
•
Perceived lack of involvement in care plan
30
Q

HTN Treatment Goals

A

Less than 140/90 for most people and diabetics

But if 80 or older, the goal is less than 150/90

CV (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions